Avacta Group (AVCTF) News Today → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free AVCTF Stock Alerts $0.59 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartShort InterestStock AnalysisChartShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAvacta Group - AVA6000 Abstract Release by AACR and Full Presentation Updatefinance.yahoo.com - April 5 at 5:55 PMAvacta Group PLC AVCTFmorningstar.com - April 4 at 10:27 AMAvacta Group PLC AVCTmorningstar.com - November 11 at 12:03 AMAvacta Group's (LON:AVCT) growing losses don't faze investors as the stock soars 11% this past weekfinance.yahoo.com - November 8 at 9:14 AMAvacta to present promising new data from Affimer® and pre|CISIONTM platform assets at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeuticsfinance.yahoo.com - October 5 at 9:22 AMAvacta Group Plc (LON:AVCT) is largely controlled by institutional shareholders who own 53% of the companyfinance.yahoo.com - September 7 at 7:55 AMAvacta sees shares rise on new equity payment for South Korea venturelse.co.uk - June 5 at 9:52 AMAvacta Group's (LON:AVCT) investors will be pleased with their solid 218% return over the last five yearsfinance.yahoo.com - June 1 at 10:45 AMAvacta Group Plc's (LON:AVCT) Business Is Trailing The Industry But Its Shares Aren'tfinance.yahoo.com - May 5 at 8:41 AMAvacta Group's Shares Rise on US Site Openings for Cancer Study Patient Enrolmentmarketwatch.com - April 7 at 2:08 AMAvacta doses first patient in fifth cohort of AVA6000 phase 1 studylse.co.uk - April 6 at 3:40 PMAvacta opens first two clinical investigator sites in US for AVA6000lse.co.uk - April 6 at 10:39 AMAvacta Announces First Patient Dosed in Fifth Cohort of AVA6000 Phase Ia Dose Escalation Studyfinance.yahoo.com - April 5 at 8:34 AMAvacta to Present Pre-Clinical Data on AVA3996 at the American Association for Cancer Research Annual Meetingfinance.yahoo.com - April 1 at 8:22 AMAvacta Group plc: Avacta Appoints Karen Harrison as Chief Operating Officer for Therapeutics Divisionfinanznachrichten.de - March 31 at 12:20 PMAvacta Group Plc (LON:AVCT) is favoured by institutional owners who hold 55% of the companyfinance.yahoo.com - March 31 at 7:07 AMAvacta Announces Successful Completion of Fourth Dose Escalation in AVA6000 Phase 1 Clinical Studybenzinga.com - January 17 at 4:59 AMInvestors in Avacta Group (LON:AVCT) have made a incredible return of 538% over the past three yearsfinance.yahoo.com - December 1 at 8:39 AMAvacta Groupfool.co.uk - September 11 at 7:57 AMAvacta Announces AVA6000 Receives Orphan Drug Designation From the US Food and Drug Administrationfinance.yahoo.com - September 5 at 5:23 AMAvacta Announces Phase I Clinical Study of AVA6000 to Advance to the Fourth Cohortfinance.yahoo.com - September 1 at 7:38 AMEven though Avacta Group (LON:AVCT) has lost UK£39m market cap in last 7 days, shareholders are still up 304% over 3 yearsfinance.yahoo.com - May 3 at 6:12 PMAvacta Announces AffyXell Joint Venture Milestone and Increased Equity Stakefinance.yahoo.com - April 13 at 10:14 AMWhat You Need To Know About Avacta Group Plc's (LON:AVCT) Investor Compositionfinance.yahoo.com - January 18 at 2:08 AMAvacta Announces FDA Approval of its Investigational New Drug (IND) Application for AVA6000finance.yahoo.com - November 29 at 8:26 AMAvacta Group (LON:AVCT) shareholder returns have been enviable, earning 486% in 3 yearsfinance.yahoo.com - November 19 at 9:41 AM Get Avacta Group News Delivered to You Automatically Sign up to receive the latest news and ratings for AVCTF and its competitors with MarketBeat's FREE daily newsletter. Email Address Exposed: 10 CENT Crypto to Explode April 20th? (Ad)The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon… Click For My #1 FREE Crypto for 2024 AVCTF Media Mentions By Week AVCTF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVCTF News Sentiment▼1.000.39▲Average Medical News Sentiment AVCTF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVCTF Articles This Week▼10▲AVCTF Articles Average Week Get Avacta Group News Delivered to You Automatically Sign up to receive the latest news and ratings for AVCTF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AGNPF News Today AKBLF News Today DRTSW News Today ARNI News Today ARTLW News Today ASCLF News Today AWKNF News Today AXIM News Today BRRGF News Today BCTXW News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:AVCTF) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour Money is Not SafeAmerican AlternativeFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avacta Group Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
